###begin article-title 0
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 83 87 <span type="species:ncbi:10116">Rats</span>
Regional Gene Expression of LOX-1, VCAM-1, and ICAM-1 in Aorta of HIV-1 Transgenic Rats
###end article-title 0
###begin p 1
Conceived and designed the experiments: USK HG AML AK. Performed the experiments: AMFH USK SFP. Analyzed the data: AMFH AK. Contributed reagents/materials/analysis tools: USK SFP HG AML AK. Wrote the paper: AMFH AK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Increased prevalence of atherosclerotic cardiovascular disease in HIV-infected patients has been observed. The cause of this accelerated atherosclerosis is a matter of controversy. As clinical studies are complicated by a multiplicity of risk-factors and a low incidence of hard endpoints, studies in animal models could be attractive alternatives.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 191 196 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 209 212 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 218 222 <span type="species:ncbi:10116">rats</span>
###xml 440 443 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 448 452 <span type="species:ncbi:10116">rats</span>
###xml 522 525 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 530 534 <span type="species:ncbi:10116">rats</span>
We evaluated gene expression of lectin-like oxidized-low-density-lipoprotein receptor-1 (LOX-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) in HIV-1 transgenic (HIV-1Tg) rats; these genes are all thought to play important roles in early atherogenesis. Furthermore, the plasma level of sICAM-1 was measured. We found that gene expressions of LOX-1 and VCAM-1 were higher in the aortic arch of HIV-1Tg rats compared to controls. Also, the level of sICAM-1 was elevated in the HIV-1Tg rats compared to controls, but the ICAM-1 gene expression profile did not show any differences between the groups.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 8 12 <span type="species:ncbi:10116">rats</span>
###xml 136 139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 200 203 <span type="species:ncbi:10116">rat</span>
###xml 290 293 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-1Tg rats have gene expression patterns indicating endothelial dysfunction and accelerated atherosclerosis in aorta, suggesting that HIV-infection per se may cause atherosclerosis. This transgenic rat model may be a very promising model for further studies of the pathophysiology behind HIV-associated cardiovascular disease.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 570 573 570 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Kline1">[1]</xref>
###xml 575 578 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Kotler1">[2]</xref>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 987 993 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 48 76 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 78 81 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 251 254 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 393 396 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 557 560 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
###xml 973 976 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The morbidity and mortality among patients with human immunodeficiency virus (HIV) infection has declined dramatically since the introduction of antiretroviral therapy (ART). Concomitantly, increased rates of atherosclerotic cardiovascular disease in HIV-infected patients have been observed. However, the cause of accelerated atherosclerosis behind most cardiovascular diseases, developed by HIV-patients, is still a matter of controversy. Three possibilities have been suggested: the infection itself, the treatment used or the dyslipidemia often seen in HIV-patients [1], [2]. The clinical studies are limited by the fact that the patients are influenced not by one but many factors, including different cardiovascular risk-factors, e.g. smoking. As it is not possible to totally isolate the different causes in clinical experiments, an animal model represents an attractive alternative to investigate in detail the origin of accelerated atherosclerosis associated with HIV-infection per se.
###end p 9
###begin p 10
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Reid1">[3]</xref>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 571 574 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Reid1">[3]</xref>
###xml 575 578 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Mazzucchelli1">[6]</xref>
###xml 13 16 <span type="species:ncbi:10116">rat</span>
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 67 70 <span type="species:ncbi:10116">rat</span>
###xml 139 142 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 147 150 <span type="species:ncbi:10116">rat</span>
###xml 178 183 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 260 263 <span type="species:ncbi:10116">rat</span>
###xml 343 346 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 514 517 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 522 525 <span type="species:ncbi:10116">rat</span>
###xml 558 561 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 673 676 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 681 684 <span type="species:ncbi:10116">rat</span>
###xml 698 701 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A transgenic rat model of HIV was constructed in 2001 (the HIV-1Tg rat) based on a Sprague-Dawley x Fisher 344/NHsd F1 background [3]. The HIV-1Tg rat contains a gag-pol-deleted HIV-1 provirus regulated by a viral promoter. Several experiments have shown this rat model to display clinical manifestations resembling the manifestations seen in HIV-patients. These manifestations include wasting, skin lesions, cataract, neurological signs, and respiratory difficulty. Furthermore, the cardiac pathology seen in the HIV-1Tg rat resembles the pathology seen in HIV-patients [3]-[6]. To our knowledge, development of atherosclerosis has not previously been investigated in the HIV-1Tg rat or any other HIV animal model.
###end p 10
###begin p 11
###xml 79 82 79 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Ross1">[7]</xref>
###xml 84 87 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Endemann1">[8]</xref>
###xml 196 199 196 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Moghadasian1">[9]</xref>
###xml 134 137 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 142 146 <span type="species:ncbi:10116">rats</span>
###xml 157 161 <span type="species:ncbi:10116">rats</span>
The first stage of atherosclerosis is considered to be endothelial dysfunction [7], [8]. As we want to investigate atherosclerosis in HIV-1Tg rats, although rats do not normally have this disease [9], we have chosen to focus on targets that are characteristic of the earliest stage of atherosclerosis. The three targets used in this study are: lectin-like oxidized-low-density-lipoprotein receptor-1 (LOX-1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1).
###end p 11
###begin p 12
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 487 491 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Ogura1">[10]</xref>
###xml 493 497 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Dunn1">[11]</xref>
Oxidized low-density lipoprotein (oxLDL) is important in the initiation and development of atherosclerosis. The primary endothelial receptor of oxLDL, LOX-1, is responsible for binding, internalization, and degradation of oxLDL in endothelial cells. Both in vitro and in vivo experiments have shown the receptor to be important in the initiation of atherosclerosis and to be up-regulated by pro-atherogenic factors, e.g. shear stress, tumor necrosis factor (TNF)-alpha, and oxLDL itself [10], [11].
###end p 12
###begin p 13
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Galkina1">[12]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Rao1">[13]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Lawson1">[14]</xref>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
VCAM-1 and ICAM-1 also play important roles in the process of atherosclerosis as they are vital to leukocyte attachment, rolling, and trans-endothelial migration. VCAM-1 is primarily an inducible molecule, whereas ICAM-1 is also constitutively expressed on resting endothelial cells. They are both up-regulated by pro-atherogenic factors. VCAM-1 has, based on experiments with knockout mice, been recognized as the crucial adhesion molecule in the initiation of atherosclerosis [12], [13]. A high level of soluble ICAM-1 (sICAM-1) in plasma has been linked to increased risk of cardiovascular events, as well as to cancer and autoimmune diseases [14].
###end p 13
###begin p 14
###xml 114 117 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 122 126 <span type="species:ncbi:10116">rats</span>
###xml 193 196 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The aim of the present study was to look at regional gene expression of LOX-1, VCAM-1, and ICAM-1 in the aorta of HIV-1Tg rats to identify possible signs of accelerated atherogenesis caused by HIV. Furthermore, the plasma level of sICAM-1 was measured.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Gene Expression
###end title 16
###begin p 17
###xml 26 33 26 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008170-g001">Fig. 1A</xref>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 88 91 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 96 100 <span type="species:ncbi:10116">rats</span>
###xml 121 125 <span type="species:ncbi:10116">rats</span>
###xml 265 269 <span type="species:ncbi:10116">rats</span>
Gene expression of LOX-1 (Fig. 1A) was significantly up-regulated in the aortic arch of HIV-1Tg rats compared to control rats (3.4-fold, p = 0.041). A tendency to LOX-1 up-regulation in the thoracic (p = 0.13) and abdominal aorta (p = 0.14) compared to the control rats was also present, although non-significant.
###end p 17
###begin title 18
###xml 77 78 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Gene expression relative to the calibrator (RQC) expressed as mean +/-SEM of n = 8-12.
###end title 18
###begin p 19
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 58 63 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</sup>
###xml 63 64 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 130 131 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 176 181 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</sup>
###xml 181 182 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 247 262 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;&#916;&#916;</sup>
###xml 262 263 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 52 56 <span type="species:ncbi:10116">rats</span>
###xml 78 82 <span type="species:ncbi:10116">rats</span>
###xml 150 153 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 170 174 <span type="species:ncbi:10116">rats</span>
###xml 188 191 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 196 200 <span type="species:ncbi:10116">rats</span>
###xml 278 282 <span type="species:ncbi:10116">rats</span>
(A) LOX-1: *p<0.05 aortic arch, HIV-1Tg vs. control rats; Deltap<0.05 control rats, aortic arch vs. abdominal aorta. (B) VCAM-1: *p<0.05 aortic arch, HIV-1Tg vs. control rats; Deltap<0.05 HIV-1Tg rats, aortic arch vs. abdominal aorta. (C) ICAM-1: DeltaDeltaDeltap<0.001 control rats, aortic arch vs. abdominal aorta.
###end p 19
###begin p 20
###xml 27 34 27 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008170-g001">Fig. 1B</xref>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 89 92 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 97 101 <span type="species:ncbi:10116">rats</span>
###xml 126 130 <span type="species:ncbi:10116">rats</span>
###xml 223 226 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 243 247 <span type="species:ncbi:10116">rats</span>
###xml 252 255 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 260 264 <span type="species:ncbi:10116">rats</span>
Gene expression of VCAM-1 (Fig. 1B) was significantly up-regulated in the aortic arch of HIV-1Tg rats compared to the control rats (1.5-fold, p = 0.044). No differences were found in the thoracic or abdominal aorta between HIV-1Tg and control rats. In HIV-1Tg rats the gene expression level for VCAM-1 was higher in the aortic arch compared to the abdominal aorta (1.9-fold, p = 0.011).
###end p 20
###begin p 21
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008170-g001">Fig. 1C</xref>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 92 96 <span type="species:ncbi:10116">rats</span>
There were no significant differences in ICAM-1 gene expression between HIV-1Tg and control rats (Fig. 1C).
###end p 21
###begin title 22
Plasma Level of sICAM-1
###end title 22
###begin p 23
###xml 40 46 40 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008170-g002">Fig. 2</xref>
The plasma level of sICAM-1 is shown in Fig. 2.
###end p 23
###begin title 24
###xml 56 57 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
The plasma level of sICAM-1 expressed as mean +/-SEM of n = 8-12.
###end title 24
###begin p 25
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 29 33 <span type="species:ncbi:10116">rats</span>
**p<0.01 HIV-1Tg vs. control rats.
###end p 25
###begin p 26
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&#8202;=&#8202;</italic>
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
###xml 80 84 <span type="species:ncbi:10116">rats</span>
sICAM-1 was significantly increased in the HIV-1Tg rats compared to the control rats (1.7-fold, p = 0.009). The range of sICAM-1 was 4.3-17.2 ng/mL.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 456 459 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Moghadasian1">[9]</xref>
###xml 112 115 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 120 124 <span type="species:ncbi:10116">rats</span>
###xml 145 149 <span type="species:ncbi:10116">rats</span>
###xml 242 245 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 255 259 <span type="species:ncbi:10116">rats</span>
###xml 376 380 <span type="species:ncbi:10116">rats</span>
###xml 451 455 <span type="species:ncbi:10116">rats</span>
###xml 537 540 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 545 549 <span type="species:ncbi:10116">rats</span>
###xml 568 571 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 576 579 <span type="species:ncbi:10116">rat</span>
###xml 670 673 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Here we show for the first time that gene expression of LOX-1 and VCAM-1 are up-regulated in the aortic arch of HIV-1Tg rats compared to control rats. In contrast, the gene expression of ICAM-1 was not signficantly up-regulated. Although the HIV-infected rats did not display overt atherosclerosis, the up-regulation of LOX-1 and VCAM-1 indicates early atherogenesis in these rats. Therefore, even though overt atherosclerosis is normally not seen in rats [9], our study indicates that early, pre-atherosclerosis can still be studied in HIV-1Tg rats. Accordingly, the HIV-1Tg rat-model seems suitable for further studies of development of accelerated atherosclerosis in HIV.
###end p 28
###begin p 29
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-FiskerHag1">[15]</xref>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Nakashima1">[16]</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
The up-regulation of LOX-1 and VCAM-1, but not ICAM-1 is in line with our previous study of pre-atherosclerotic apoE-/- mice [15]. According to that study, ICAM-1 did not seem to play a role in atherogenesis as early as LOX-1 and VCAM-1. Another study using immunohistochemistry found VCAM-1 to be up-regulated in 20 weeks old apoE-/- mice compared to control mice. The up-regulation of VCAM-1 was further increased by high-fat diet, whereas ICAM-1 was unaffected by both apoE-deficiency and high-fat diet [16]. These studies support that our findings in the present study are signs of early atherosclerosis.
###end p 29
###begin p 30
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Zarins1">[17]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Passerini1">[18]</xref>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Brooks1">[19]</xref>
###xml 1067 1075 1067 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1080 1087 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1253 1257 1253 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Davies1">[20]</xref>
###xml 1259 1263 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Brooks2">[21]</xref>
###xml 361 365 <span type="species:ncbi:9823">pigs</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 1314 1317 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The significant up-regulation of LOX-1 and VCAM-1 in the aortic arch but not in the other areas of the aorta is not unexpected. It has long been known that specific patterns of shear stress influence gene expression in the vessel wall. The initial observation was that atherosclerosis develops in a non-random pattern [17] . A study of aortas from normal adult pigs showed higher expression of pro-inflammation associated genes in the aortic arch than in the thoracic aorta. They concluded that regions with low shear stress (aortic arch) were more atherosclerosis-susceptible than regions with laminar flow and high shear stress (thoracic aorta) [18]. Numerous studies of cell cultures using different flow apparatuses have demonstrated the association between the hemodynamics of vessels and the expression of pro-atherosclerotic genes. A study from 2002 using human aortic endothelial cells showed VCAM-1 to be up-regulated by disturbed flow which is characteristic of the aortic arch. The expression of ICAM-1 was only transiently upregulated [19]. Based on both in vitro and in vivo experiments, the overall conclusion is that low, disturbed, or oscillating flow patterns promote a pro-inflammatory phenotype that paves the way for atherosclerosis [20], [21]. In accordance with this, we found indications of HIV-induced accelerated atherosclerosis in the aortic arch, where low and oscillating flow is present.
###end p 30
###begin p 31
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Mastroianni1">[22]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Kristoffersen1">[23]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Lawson1">[14]</xref>
###xml 50 53 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 58 62 <span type="species:ncbi:10116">rats</span>
###xml 83 87 <span type="species:ncbi:10116">rats</span>
###xml 181 184 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
We found that sICAM-1 was significantly higher in HIV-1Tg rats compared to control rats. In accordance with our results, clinical studies have shown that sICAM-1 is up-regulated in HIV-patients compared to non-infected individuals [22], [23]. The origin of sICAM-1 is so far unknown [14]. The higher plasma level of sICAM-1 without upregulation of the gene expression of ICAM-1 in the aorta indicates that vessels may not be the major source of sICAM-1.
###end p 31
###begin p 32
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Mu1">[24]</xref>
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 159 162 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 298 301 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 306 309 <span type="species:ncbi:10116">rat</span>
The relevance of specific HIV-proteins to the development of atherosclerosis has so far not been fully revealed. Until now the research calls attention to the HIV proteins Tat, gp120 and Nef as possible mediators of endothelial dysfunction [24]. As these proteins are expressed in all cells of the HIV-1Tg rat, this study cannot disclose their relevance for the disease. However, it could be an interesting future area of investigation to study the impact of these proteins on atherogenesis in an animal model.
###end p 32
###begin p 33
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 23 27 <span type="species:ncbi:10116">rats</span>
###xml 137 140 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 194 197 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 202 205 <span type="species:ncbi:10116">rat</span>
###xml 281 284 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 382 385 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 534 537 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In conclusion, HIV-1Tg rats have gene expression patterns indicating accelerated atherosclerosis in the aortic arch. This indicates that HIV-infection per se seems to cause atherosclerosis. The HIV-1Tg rat may be a promising model for further studies of the pathophysiology behind HIV-related cardiovascular disease, e.g. time-course of the atherogenesis and relative importance of HIV-infection and anti-retroviral treatment. Furthermore, it will be interesting to study how different risk-factors, e.g. high-fat diet, influence the HIV-related atherogenesis.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
Experimental Model
###end title 35
###begin p 36
Animal care and all experimental procedures were performed under the approval of the Danish Animal Welfare Council.
###end p 36
###begin p 37
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 28 32 <span type="species:ncbi:10116">rats</span>
###xml 102 106 <span type="species:ncbi:10116">rats</span>
Eight male HIV-1 transgenic rats and 12 parental wild-type inbred F344/NHsd control background strain rats were purchased from Harlan (IN, USA).
###end p 37
###begin p 38
###xml 4 8 <span type="species:ncbi:10116">rats</span>
###xml 123 126 <span type="species:ncbi:10116">rat</span>
The rats were housed under humidity-, temperature-, and light cycle-controlled conditions, and had free access to standard rat diet and water throughout the course of experiments.
###end p 38
###begin title 39
Sample Handling
###end title 39
###begin p 40
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
At the age of 10-12 months, the animals were anesthetized with 3% sevoflurane (Abbott Scandinavia AB, Sweden) mixed with 35% O2 in N2 by breathing and subsequently decapitated. Blood was collected, centrifuged, and plasma transferred to a fresh tube and stored at -20degreesC.
###end p 40
###begin p 41
The aorta was removed and divided into the aortic arch, the thoracic aorta, and the abdominal aorta. The samples were placed in RNAlater(R) (Ambion (Europe) Limited, UK) and stored at 4degreesC. The following day RNAlater(R) was removed and the samples were stored at -80degreesC.
###end p 41
###begin title 42
RNA Extraction and Reverse Transcription
###end title 42
###begin p 43
###xml 222 225 <span type="species:ncbi:9685">cat</span>
Total RNA was isolated with TRI Reagent(R) (Molecular Research Center Inc., OH, USA), and 0.3 microg total RNA was reversed transcribed using the AffinityScripttrade mark QPCR cDNA Synthesis Kit from (Stratagene, CA, USA, cat.# 600559). Samples were cooled down and stored at -20degreesC.
###end p 43
###begin title 44
Real-Time qPCR
###end title 44
###begin p 45
###xml 472 473 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 313 316 <span type="species:ncbi:9685">cat</span>
Gene expression was quantified on the Mx3000P(R) and Mx3005Ptrade mark real-time PCR systems from Stratagene. LOX-1 was quantified in a duplex with glyceraldehydes-3-phosphate dehydrogenase (GAPDH), while VCAM-1, ICAM-1, and GAPDH were quantified in a triplex. The Brilliant(R) QPCR Core Reagent Kit (Stratagene, cat.# 600530) was used. Optimization of assays resulted in a 50% and 100% increase of dNTP and Taq polymerase for the duplex and triplex, respectively. An MgCl2 concentration of 5.5 mM was found to be optimal for all experiments. The thermal profile used was: 10 min of denaturation at 95degreesC followed by 45 cycles with denaturation for 30 s at 95degreesC and annealing/elongation at 60degreesC for 1 min.
###end p 45
###begin p 46
###xml 52 65 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 67 71 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Livak1">[25]</xref>
###xml 141 145 <span type="species:ncbi:10116">rats</span>
Relative quantification by the comparative method (2-DeltaDeltaCt) [25] was used. A calibrator consisting of a pool of cDNA from all control rats was used. Furthermore, the measurements were corrected for the efficiency of the PCR reaction, calculated from 5-fold dilution curves, thereby replacing 2 in the formula with (1+E).
###end p 46
###begin p 47
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Andersen1">[26]</xref>
###xml 217 221 <span type="species:ncbi:10116">rats</span>
The optimal housekeeping gene for the study was selected from a panel of twelve common endogenous control genes (pre-fabricated panel from PrimerDesign, UK). All 12 genes were tested by qPCR in both HIVTg and control rats. NormFinder [26] was used to find the optimal housekeeping gene. GAPDH was found to be the most representative housekeeping gene.
###end p 47
###begin p 48
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008170-t001">Table 1</xref>
Primers and TaqMan dual-labeled probes for the three genes of interest LOX-1 (NM_133306), VCAM-1 (NM_012889), and ICAM-1 (NM_012967) along with the housekeeping gene GAPDH (NM_017008) were designed using Beacon Designer (PREMIER Biosoft, CA, USA). Primers and probes are shown Table 1. All primers and probes were purchased from Eurofins MWG (Ebergsberg, Germany).
###end p 48
###begin title 49
Primers and probes.
###end title 49
###begin p 50
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008170-t002">Table 2</xref>
For each gene, the optimal primer and probe concentration was established (Table 2). All samples were run as triplicates using 1 microL of cDNA.
###end p 50
###begin title 51
Optimal filter setting, primer- and probe-concentration for the genes investigated.
###end title 51
###begin title 52
Plasma Measurements
###end title 52
###begin p 53
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-Carson1">[27]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008170-De1">[28]</xref>
###xml 125 128 <span type="species:ncbi:9685">cat</span>
All plasma samples were measured using a bead-based sandwich immunoassay technique [27], [28]. A commercially available kit (cat.# RCVD2-89K-01, LINCO Research, MO, USA) was used. The samples were analyzed on the Luminextrade mark LX100 with STarStation 2.0 software (Millipore Corporation, MA, USA).
###end p 53
###begin title 54
Statistical Analysis
###end title 54
###begin p 55
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
All data were tested by means of Kolmogorov-Smirnov and found to be normal distributed. Comparisons between the different rat groups were performed by Student's t-test for independent samples and between regions of aorta with a paired t-test. Bonferroni corrections for planned comparisons were performed when more than two groups were compared. P<0.05 was considered significant.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.
###end article-title 57
###begin article-title 58
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 90 93 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
###end article-title 58
###begin article-title 59
###xml 3 8 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 20 23 <span type="species:ncbi:10116">rat</span>
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.
###end article-title 59
###begin article-title 60
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 25 28 <span type="species:ncbi:10116">rat</span>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy.
###end article-title 60
###begin article-title 61
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 17 21 <span type="species:ncbi:10116">rats</span>
HIV-1 transgenic rats develop T cell abnormalities.
###end article-title 61
###begin article-title 62
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 152 156 <span type="species:ncbi:10116">rats</span>
Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats.
###end article-title 62
###begin article-title 63
Atherosclerosis-an inflammatory disease.
###end article-title 63
###begin article-title 64
Endothelial dysfunction.
###end article-title 64
###begin article-title 65
Experimental atherosclerosis: a historical overview.
###end article-title 65
###begin article-title 66
LOX-1.
###end article-title 66
###begin article-title 67
The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
###end article-title 67
###begin article-title 68
Vascular adhesion molecules in atherosclerosis.
###end article-title 68
###begin article-title 69
Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall.
###end article-title 69
###begin article-title 70
ICAM-1 signaling in endothelial cells.
###end article-title 70
###begin article-title 71
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice.
###end article-title 71
###begin article-title 72
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.
###end article-title 72
###begin article-title 73
Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress.
###end article-title 73
###begin article-title 74
Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta.
###end article-title 74
###begin article-title 75
###xml 29 34 <span type="species:ncbi:9606">human</span>
Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow.
###end article-title 75
###begin article-title 76
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology.
###end article-title 76
###begin article-title 77
Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis.
###end article-title 77
###begin article-title 78
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.
###end article-title 78
###begin article-title 79
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.
###end article-title 79
###begin article-title 80
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Current update on HIV-associated vascular disease and endothelial dysfunction.
###end article-title 80
###begin article-title 81
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 81
###begin article-title 82
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.
###end article-title 82
###begin article-title 83
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay.
###end article-title 83
###begin article-title 84
###xml 29 34 <span type="species:ncbi:9606">human</span>
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.
###end article-title 84
###begin p 85
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 85
###begin p 86
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The financial support from Novo Nordisk Foundation (), Lundbeck Foundation (), A.P. Moller Foundation (), The Danish Heart Foundation (grant no. 09-04-R72-A2356-22560; ), and Danish Medical Research Council (grant no. 959592772; ) is gratefully acknowledged. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 86

